BioWorld

July 29, 2003

Clusterin Protein May Improve Important, Lifesaving Early Colon Cancer Call Over Colonoscopy

OxiGene Gets Orphan Status For CA4P; Stock Soars 50 Percent

Other News To Note

MGI Offering Could Gross $128M Following FDA Approval Of Aloxi

Capitalizing on a stock surge prompted by Friday's approval of a partnered cancer drug, MGI Pharma Inc. on Monday reported plans to sell 4 million shares. (BioWorld Today) Read More

ISTA Gets Approvable Letter On Product To Treat Glaucoma

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...

Illustration of Alzheimer's disease in the brain

ADPD 2026: Three inflection points to target Alzheimer’s disease

BioWorld Science

A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...